Xconomy National

Archives

by in

Entry	Author	Date	Location
ASCO Wrap-Up: The Skinny on Cancer News From All Corners of the U.S.	Luke Timmerman	06/07/11	National
Adriana Jenkins, Boston Biotech PR Maven, Dies from Breast Cancer at 41	Luke Timmerman	02/10/11	Boston
CalciMedica Charges Ahead Toward First Human Test of Oral Pill for Psoriasis	Luke Timmerman	10/20/10	San Diego
After the Meltdown: Synta Pharma CEO Trumpets New Top Cancer Drug	Ryan McBride	07/12/10	Boston
Genzyme Reaches Agreement with Activist Investor, Charles River Closes Shrewsbury Lab, Lycera Comes to Cambridge, & More Boston-Area Life Sciences News	Rebecca Zacks	01/13/10	Boston
Synta Nabs $25M in Stock Deal	Luke Timmerman	01/08/10	Boston
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten	Luke Timmerman	10/08/09	Boston
Merck and Roche Back Adimab, Viral Contamination Closes Genzyme Plant, Interlace Ties on $20.5M, & More Boston-Area Life Sciences News	Rebecca Zacks	06/17/09	Boston
Glaxo Ends Synta Partnership	Luke Timmerman	06/15/09	Boston
ASCO Weekend Highlights: ImmunoGen, Antigenics, Aveo Show Off Cancer Drug Findings	Luke Timmerman	06/01/09	Boston
ASCO Sneak Peek: ImmunoGen, Biogen Idec, Infinity Show Glimpses of Cancer Drug Data	Luke Timmerman	05/15/09	Boston
TargAnox Launches with $5.1M Series A Round, Targeting Oxidative Stress to Treat Diseases	Ryan McBride	03/30/09	Boston
Funding Pool Deep for Still River, Cuts in the Offing for Epix and Synta, FDA Approvals Granted for Hologic, & More Boston-Area Life Sciences News	Rebecca Zacks	03/18/09	Boston
Biotech Survival Index 2: Boston Life Sciences Companies Squirrel Away More Cash for Long Winter	Luke Timmerman	03/17/09	Boston
Synta Pharma Cuts 90 Workers	Ryan McBride	03/13/09	Boston
Synta Melanoma Drug Trial Halted, Drug Regulators Hand Genzyme Mixed Bag, Ariad and ImmunoGen Reach Milestones, & More Boston-Area Life Sciences News	Rebecca Zacks	03/04/09	Boston
Synta Melanoma Drug Fails Disastrously in Clinical Trial, As Patients Show Higher Death Rate	Luke Timmerman	02/26/09	Boston
Vertex’s $320M SPO, Verenium and BP’s Joint Venture, Genocea’s $23M Series A, & More Boston-Area Deals News	Rebecca Zacks	02/20/09	Boston
Alkermes Aims for Big Time, Partners Launches Blood Pressure Tracker, Synta Gets GSK Payday, & More Boston-Area Life Sciences News	Rebecca Zacks	02/18/09	Boston
GSK Pays Synta $10M Milestone Fee	Ryan McBride	02/17/09	Boston
Harvard Researcher to Helm Merck’s Cancer Research, Genzyme Acquires Certain Exact Sciences Assets, NeurAxon Out to Axe Migraines, & More Boston-Area Life Sciences	Rebecca Zacks	02/04/09	Boston
Synta Melanoma Data Coming in May	Luke Timmerman	02/02/09	Boston
Regulus Strikes Out On Its Own, J&J Seeks “Enlight”-enment, Synta Awaits Melanoma Data, & More Boston-Area Life Sciences News	Rebecca Zacks	01/28/09	Boston
Synta, Developer of New Class of Cancer Drugs, Eagerly Awaits Results From Key Trial	Luke Timmerman	01/27/09	Boston
CalciMedica Finds a New Pathway to Fight Autoimmune Disorders	Bruce V. Bigelow	01/09/09	San Diego
Forma Emerges With Well-Formed Cancer-Drug Strategy, Biogen Idec Preps for Parkinson’s Drug Data, Endo Buys out Indevus, & More Boston-Area Life Sciences News	Rebecca Zacks	01/07/09	Boston
GSK Pays Synta $15M	Rebecca Zacks	12/12/08	Boston
Synta Snags $25M From GSK, GT Solar and Evergreen Solar Sell More Solar Stuff, Predictive Biosciences Foresees $22M, & More Boston-Area Deals News	Rebecca Zacks	10/20/08	Boston
Biogen Idec Makes Controversial Tysabri Decision, Boston Scientific Explains Stock Sales, Charles River Heads to China, & More Boston-Area Life Sciences News	Rebecca Zacks	10/16/08	Boston
Synta Gets $25M From Glaxo For Cancer Drug Milestone	Luke Timmerman	10/14/08	Boston
Page 1 of 2	next page »